The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 0 first-in-human study using NU-0129: A gold base spherical nucleic acid (SNA) nanoconjugate targeting BCL2L12 in recurrent glioblastoma patients.
 
Priya Kumthekar
Leadership - Vivacitas Oncology
Stock and Other Ownership Interests - Vivacitas Oncology
Consulting or Advisory Role - Abbvie
Research Funding - Abbvie; DNAtrix; Genentech/Roche; Novocure; Orbus Therapeutics
Patents, Royalties, Other Intellectual Property - Utility patent for ANG 1005. No financial gain, no royalties.
 
Alfred Rademaker
Research Funding - Siemens (Inst)
Other Relationship - Georgetown Univ.; JAMA-Journal of the American Medical Association
 
Caroline Ko
No Relationships to Disclose
 
Karan Dixit
No Relationships to Disclose
 
Margaret A. Schwartz
Speakers' Bureau - Novocure; Novocure
 
Adam M. Sonabend
Research Funding - Tocagen
Patents, Royalties, Other Intellectual Property - Provisional patent on the use of TOP2 inhibitors for gliomas (not commercialized as of now).
 
Laura Sharp
No Relationships to Disclose
 
Rimas Vincas Lukas
No Relationships to Disclose
 
Roger Stupp
Employment - Celgene (I)
Stock and Other Ownership Interests - Celgene (I)
Consulting or Advisory Role - Celgene (Inst); Debiopharm Group (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); UCB (Inst)
Travel, Accommodations, Expenses - Novocure
 
Craig Horbinski
No Relationships to Disclose
 
Kathleen McCortney
No Relationships to Disclose
 
Alexander H. Stegh
Stock and Other Ownership Interests - Exicure
Consulting or Advisory Role - Exicure